S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Experts: NVIDIA Now "Too Big to Succeed" (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Experts: NVIDIA Now "Too Big to Succeed" (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Experts: NVIDIA Now "Too Big to Succeed" (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Experts: NVIDIA Now "Too Big to Succeed" (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Experts: NVIDIA Now "Too Big to Succeed" (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Experts: NVIDIA Now "Too Big to Succeed" (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Experts: NVIDIA Now "Too Big to Succeed" (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Experts: NVIDIA Now "Too Big to Succeed" (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Experts: NVIDIA Now "Too Big to Succeed" (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Experts: NVIDIA Now "Too Big to Succeed" (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Experts: NVIDIA Now "Too Big to Succeed" (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Experts: NVIDIA Now "Too Big to Succeed" (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
NYSEARCA:XBI

SPDR S&P Biotech ETF (XBI) Price, Holdings, & News

$73.02
-0.75 (-1.02%)
(As of 09/29/2023 ET)
Compare
Today's Range
$72.81
▼
$74.68
50-Day Range
$71.89
▼
$84.33
52-Week Range
$71.59
▼
$92.60
Volume
10.42 million shs
Average Volume
7.88 million shs
Market Capitalization
$5.60 billion
Assets Under Management
$5.43 billion
Dividend Yield
N/A
Net Expense Ratio
0.35%
ProfileChartHeadlinesHoldingsOptions ChainRatings
XBI stock logo

About SPDR S&P Biotech ETF (NYSEARCA:XBI)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.

XBI Price History

XBI ETF News Headlines

September 29, 2023 | realmoney.thestreet.com
Small Biotech Stocks Haven't Shined of Late, but I Think These 3 Could Be Stars
September 27, 2023 | realmoney.thestreet.com
Anxiety Creeps Back Into the Markets, but I Think Outright Panic Could Lie Ahead
October 1, 2023 | Goldco (Ad)
Biden's Digital Dollar Nightmare
On July 20th, 2023, the Federal Reserve launched FedNow, which could spark the fuse for a Digital Dollar. If a Digital Dollar happens, the government could: Monitor every transaction, keep track of your spending habits, and potentially control your individual choices… Which MAY steal your freedoms in one way or another. And if you don’t plan for this now... Your retirement savings could be at risk of being frozen, hacked, or deleted. You’ll want to act fast... Because with Biden’s long history of voting against Americans... Who knows how much longer until Biden strikes again! Get your hands on this FREE Wealth Protection Kit today and learn how you could shield your savings and investments before it’s too late!
September 25, 2023 | theglobeandmail.com
September Puts Options Trades Update #4
September 20, 2023 | msn.com
6 Healthcare Stocks Analysts Still Like
September 13, 2023 | markets.businessinsider.com
Buy List Alert: 3 Pharma Stocks with Positive Trial Updates
July 18, 2023 | finance.yahoo.com
Novartis Stock Buyback Flashes Yellow Light for Biotech Stocks
July 13, 2023 | msn.com
Moderna: Buy While It's Cheap (Rating Upgrade)
October 1, 2023 | Goldco (Ad)
Biden's Digital Dollar Nightmare
On July 20th, 2023, the Federal Reserve launched FedNow, which could spark the fuse for a Digital Dollar. If a Digital Dollar happens, the government could: Monitor every transaction, keep track of your spending habits, and potentially control your individual choices… Which MAY steal your freedoms in one way or another. And if you don’t plan for this now... Your retirement savings could be at risk of being frozen, hacked, or deleted. You’ll want to act fast... Because with Biden’s long history of voting against Americans... Who knows how much longer until Biden strikes again! Get your hands on this FREE Wealth Protection Kit today and learn how you could shield your savings and investments before it’s too late!
July 12, 2023 | finance.yahoo.com
Recursion Pharmaceuticals Stock Surges On Nvidia Investment
See More Headlines
Receive XBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SPDR S&P Biotech ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
SSgA
Fund Name
SPDR S&P Biotech ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:XBI
Inception Date
1/31/2006
Fund Manager
Michael Feehily, Karl Schneider, Raymond Donofrio
Web
www.spdrs.com
Phone
+1-866-7872257

Fund Focus

Asset Class
Equity
Benchmark
S&P Biotech Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
137

Fund Statistics

Assets Under Management
$5.43 billion
Average Daily Volume
$10.20 million
Discount/Premium
-0.05%

Administrator, Advisor and Custodian

Administrator
SSgA Funds Management, Inc.
Advisor
SSgA Funds Management, Inc.
Custodian
State Street Bank and Trust Company
Distributor
State Street Global Advisors Funds Distributors, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
66,219
Put Options
27,020
Call Options
39,199
Short Interest
42,130,000 shs

Miscellaneous

Outstanding Shares
76,700,000
Beta
0.97
Creation Unit
50,000
Creation Fee
$250.00
Elon Musk's Next Move Cover
Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

SPDR S&P Biotech ETF Expenses

TypeXBIHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.35%0.57%0.53%0.50%0.50%
Other Expenses0.00%0.40%0.52%0.64%0.57%
Total Expense0.35%0.72%0.69%0.74%0.69%
Fee Waiver0.00%-0.51%-0.55%-0.70%-0.59%
Net Expense0.35%0.61%0.59%0.57%0.57%

SPDR S&P Biotech ETF (XBI) Holdings & Exposure

Top 10 XBI Holdings

XBI Sector Exposure

XBI Industry Exposure

Full Holdings Details

Key Executives

  • James E. Ross (Age 52)
    President, Trustee
  • Peter A. Ambrosini (Age 69)
    Chief Compliance Officer
  • Michael P. Riley (Age 44)
    Vice President
  • Gary L. French (Age 64)
    Treasurer
  • John W. Clark (Age 46)
    Assistant Treasurer
  • Matthew W. Flaherty (Age 42)
    Assistant Treasurer
  • Chad C. Hallett (Age 47)
    Assistant Treasurer of Street tracks series trust
  • Mary Moran Zeven (Age 52)
    Secretary
  • Scott M. Zoltowski (Age 44)
    Assistant Secretary
  • Dave Kelly
    Independent Trustee

Similar ETFs

Institutional Ownership

View All Institutional Transactions













XBI ETF - Frequently Asked Questions

How have XBI shares performed in 2023?

SPDR S&P Biotech ETF's stock was trading at $83.00 at the beginning of 2023. Since then, XBI shares have decreased by 12.0% and is now trading at $73.02.
View the best growth stocks for 2023 here.

What does XBI invest in?

SPDR S&P Biotech ETF is a equity fund issued by SSgA. XBI focuses on health care investments and follows the S&P Biotech Index. The fund's investments total to approximately $5.43 billion assets under management.

What stocks does SPDR S&P Biotech ETF hold?

XBI invests in 137 holdings. Some of the stocks in their portfolio include BridgeBio Pharma (BBIO), Revolution Medicines (RVMD), Halozyme Therapeutics (HALO), ACADIA Pharmaceuticals (ACAD), Catalyst Pharmaceuticals (CPRX), Novavax (NVAX), Neurocrine Biosciences (NBIX), AbbVie (ABBV), Incyte (INCY) and Vertex Pharmaceuticals (VRTX).

What is the management fee for SPDR S&P Biotech ETF?

SPDR S&P Biotech ETF's management fee is 0.35% and has no other recorded expenses or fee waivers. The net expense ratio for XBI is 0.35%.

What other stocks do shareholders of SPDR S&P Biotech ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SPDR S&P Biotech ETF investors own include Intel (INTC), NVIDIA (NVDA), Pfizer (PFE), Gilead Sciences (GILD), iShares Biotechnology ETF (IBB), Walt Disney (DIS), Micron Technology (MU), Cisco Systems (CSCO), AbbVie (ABBV) and Netflix (NFLX).

What is SPDR S&P Biotech ETF's stock symbol?

SPDR S&P Biotech ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "XBI."

How do I buy shares of SPDR S&P Biotech ETF?

Shares of XBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is SPDR S&P Biotech ETF's stock price today?

One share of XBI stock can currently be purchased for approximately $73.02.

How much money does SPDR S&P Biotech ETF make?

SPDR S&P Biotech ETF (NYSEARCA:XBI) has a market capitalization of $5.60 billion.

How can I contact SPDR S&P Biotech ETF?

SPDR S&P Biotech ETF's mailing address is One Lincoln Street, Boston, 02111, United States. The official website for the company is www.spdrs.com. The exchange traded fund can be reached via phone at +1-866-7872257.

This page (NYSEARCA:XBI) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -